Skip to content
For laboratory research use only · Not for human or veterinary use · Qualified buyers only
Peptides

What Is KPV? α-MSH(11-13) Identity and Laboratory Documentation

A research-use identity note on KPV, the Lys-Pro-Val C-terminal tripeptide of α-MSH, with attributed inflammatory-model findings and lot documentation.

What Is KPV? α-MSH(11-13) Identity and Laboratory Documentation

KPV is the Lys-Pro-Val tripeptide derived from the C-terminal region of α-melanocyte-stimulating hormone (α-MSH) and used in inflammatory-signaling research. The original overview of this page asks three questions: the Lys-Pro-Val sequence, inflammatory and epithelial cell models, and identity testing for a low-mass tripeptide.

Editorial review: 17 November 2026. Prepared by Velnacor Research Desk for research-use communication only. Published findings below are attributed to the cited papers. They are not claims about a Velnacor lot and are not instructions for use in people or animals.

The Lys-Pro-Val sequence

Hiltz and Lipton reported that the C-terminal tripeptide of α-MSH, lysine-proline-valine, had anti-inflammatory activity in the models they described, following earlier work on α-MSH itself (Hiltz and Lipton, 1989). Kannengiesser and colleagues later identified that tripeptide as α-MSH(11-13) (KPV) and studied it in two murine models of intestinal inflammation (Kannengiesser et al., 2008). KPV is not intact α-MSH, and it is not PT-141, a cyclic melanocortin analogue. A related melanocortin identity note is at What Is PT-141?.

A three-letter code is not a complete specification until the sequence, salt form if stated, and the report agree. Low-mass tripeptides require identity methods suited to that size.

Inflammatory-model findings — and their limits

Hiltz and Lipton reported that the C-terminal tripeptide inhibited increases in vasopermeability in the designs they used and discussed a more general anti-inflammatory activity for that fragment (Hiltz and Lipton, 1989). Kannengiesser and colleagues reported anti-inflammatory potential for KPV in murine models of inflammatory bowel disease and discussed its mode of action in those models (Kannengiesser et al., 2008). Those are published laboratory-model observations. They are not a clinical treatment claim, and they are not a use instruction.

Identity testing for a low-mass tripeptide

What Is a Peptide COA?, How to Read a Peptide COA, HPLC vs Mass Spectrometry for Peptide Lot Review, Third-Party Peptide Testing, Explained, and lot traceability apply here, with methods appropriate to a short peptide.

KPV appears in Velnacor’s research-material catalog (internal product record, slug kpv). There is not a standalone public landing page for every catalog name; use the product directory and the COA Library, then confirm the exact SKU and current-lot documents in the inquiry. For packing at supply scale, see wholesale peptides.

Low-mass tripeptides can be missed or mis-assigned if a method developed for a longer melanocortin is applied without review. The certificate should name Lys-Pro-Val or the equivalent sequence language, and the mass and purity methods should be appropriate to that size. Content, salt form if stated, and the lot number on the vial still have to match. KPV findings in inflammatory models should not be transferred to PT-141 or to intact α-MSH, and the reverse is also true.

Selected published literature

  1. Hiltz ME, Lipton JM. Antiinflammatory activity of a COOH-terminal fragment of the neuropeptide α-MSH. The FASEB Journal. 1989;3(11):2282-2284. doi:10.1096/fasebj.3.11.2550304. PubMed 2550304.
  2. Kannengiesser K, Maaser C, Heidemann J, Luegering A, Ross M, Brzoska T, Bohm M, Luger TA, Domschke W, Kucharzik T. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. 2008;14(3):324-331. doi:10.1002/ibd.20334. PubMed 18092346.

Sourcing notes for qualified buyers

Velnacor’s stated supply terms for qualified research and business buyers include: every batch is third-party tested; orders usually ship within 24 hours, subject to stock, documentation review, and destination; trial orders can start from one box of ten vials; parcels lost or damaged in transit are eligible for free reshipment or a refund; and neutral packaging is available when required. Velnacor operates its own production base and has a long-standing supply-chain business.

Those points describe documentation and fulfillment. They do not describe a laboratory or biological outcome. For an order-specific review, send the material name, specification, box quantity, and destination through the inquiry list.

Research-use notice. All Velnacor products are intended strictly for laboratory research use only. They are not drugs, supplements, or food, and are not intended to diagnose, treat, cure, or prevent any disease. Not for human or veterinary use. Purchasers must be qualified researchers. This article is educational content for laboratory and business readers. It does not provide dosing, reconstitution, administration, diagnostic, or treatment guidance.

My inquiry listNo products added yet0